Mesoderm/mesenchyme homeobox l may promote tumor progression in human hepatocellular carcinoma
Jie Ruan1, Ying Xie2, Huifang Zhou3
1Graduate School of Hebei Medical University, Shijiazhuang, China.
Background:
The clinical response rate for molecularly targeted medications is limited despite significant advancements in molecularly targeted therapy for hepatocellular carcinoma (HCC). Therefore, it is necessary to find new and robust therapeutic targets for the treatment of HCC. Recent research has shown that mesoderm/mesenchyme homeobox gene 1 (Meox1) is closely associated with cancer progression.
Objectives:
The aim of this study was to evaluate the clinical relevance as well as biological function of Meox1 in HCC.
Material And Methods:
Meox1 protein expression level was identified through immunohistochemistry (IHC) examination of pathological tissues from 25 HCC patients. The aim of the analysis was to investigate the relationship between clinicopathological traits and Meox1 expression. Biological function assays of Meox1 in HCC, including proliferation, colony formation, migration, and invasion, were performed with Huh7 and Hep3B cells.
Results:
In this study, Meox1 expression in HCC tissues was significantly higher (p < 0.05) compared to paracancerous tissues. Especially in HCC tissues of patients with cirrhosis, the level of Meox1 expression was significantly elevated when compared to HCC tissues of patients without cirrhosis (p < 0.05). High Meox1 expression was significantly associated with tumor-node-metastasis (TNM) stage (p < 0.05) and the Barcelona Clinic Liver Cancer (BCLC) stage (p < 0.05). Moreover, Meox1 silencing suppressed the proliferation, colony formation, migration, and invasion of Huh7 and Hep3B cells.
Conclusions:
Our data reveal that Meox1 may play a crucial role in the development of HCC, and given the function of Meox1 in proliferation and metastasis, targeting Meox1 may offer a promising approach for combined and adjuvant therapeutics of HCC.
Insights
Mesoderm/mesenchyme homeobox gene 1 (Meox1) is highly expressed in hepatocellular carcinoma (HCC) and promotes tumor growth and metastasis. Targeting Meox1 may offer a new therapeutic strategy for HCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Hepatocellular carcinoma (HCC) treatment response to targeted therapies remains limited.
- Novel therapeutic targets for HCC are urgently needed.
- Mesoderm/mesenchyme homeobox gene 1 (Meox1) has emerged as a potential factor in cancer progression.
Purpose of the Study:
- To investigate the clinical relevance of Meox1 in HCC.
- To elucidate the biological function of Meox1 in HCC progression.
Main Methods:
- Immunohistochemistry (IHC) was used to assess Meox1 protein levels in 25 HCC patient tissues.
- Correlation analysis was performed between Meox1 expression and clinicopathological features.
- In vitro assays (proliferation, colony formation, migration, invasion) were conducted using HCC cell lines (Huh7, Hep3B) with Meox1 silencing.
Main Results:
- Meox1 expression was significantly elevated in HCC tissues compared to adjacent non-cancerous tissues (p < 0.05).
- Higher Meox1 levels were observed in HCC patients with cirrhosis (p < 0.05).
- Increased Meox1 expression correlated significantly with advanced tumor-node-metastasis (TNM) and Barcelona Clinic Liver Cancer (BCLC) staging (p < 0.05).
- Silencing Meox1 inhibited proliferation, colony formation, migration, and invasion in HCC cell lines.
Conclusions:
- Meox1 plays a critical role in the development and progression of HCC.
- Meox1's involvement in proliferation and metastasis suggests it as a promising therapeutic target.
- Targeting Meox1 could be a valuable strategy for combined and adjuvant HCC therapies.
More Related Videos
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Hedgehog Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Induced Pluripotent Stem Cells
Somatic...
